ing. D.F. Samplonius

No picture available
E-mail:
d.f.samplonius umcg.nl

Research

Publications
  1. Modular medical imaging agents based on azide-alkyne Huisgen cycloadditions: Synthesis and pre-clinical evaluation of 18F-labeled PSMA-tracers for prostate cancer imaging

    Böhmer, V. I., Szymanski, W., van den Berg, K-O., Mulder, C., Kobauri, P., Helbert, H., van den Born, D., Reeβing, F., Huizing, A., Klopstra, M., Samplonius, D. F., Antunes, I. F., Sijbesma, J. W. A., Luurtsema, G., Helfrich, W., Visser, T. J., Feringa, B. L. & Elsinga, P. H., 21-Apr-2020, In : Chemistry. 24 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Bispecific Antibody Approach for Improved Melanoma-Selective PD-L1 Immune Checkpoint Blockade

    Koopmans, I., Hendriks, M. A. J. M., van Ginkel, R. J., Samplonius, D. F., Bremer, E. & Helfrich, W., Nov-2019, In : Journal of Investigative Dermatology. 139, 11, p. 2343-+ 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibition

    de Boer, H. R., Pool, M., Joosten, E., Everts, M., Samplonius, D. F., Helfrich, W., Groen, H. J. M., van Cooten, S., Fusetti, F., Fehrmann, R. S. N., de Vries, E. G. E. & van Vugt, M. A. T. M., 28-Feb-2019, In : ONCOGENE. 38, 9, p. 1477-1488 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint

    Koopmans, I., Hendriks, D., Samplonius, D. F., van Ginkel, R. J., Heskamp, S., Wierstra, P. J., Bremer, E. & Helfrich, W., 2018, In : OncoImmunology. 7, 8, 11 p., 1466016.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (30) »

ID: 214592